RespireRx Pharmaceuticals Inc (RSPI)

[myostrain]

Good luck but careful. Luckily I have only been invested in cortex for just over 3 years and unfortunately believe in the potential and the pharmacology behind ampakines and hope that Cortex has been and will be utilizing there cash flow appropriately and developing promising products to where they can actually come to market.

Careful with the alternative energy, that is another sector I have enjoyed researching but is in many ways seems more risk>reward than biotech.